Vivek Sharma Appointed Executive Chairman of Suven Pharmaceuticals

Suven Pharmaceuticals Ltd. has announced the appointment of Vivek Sharma as the company’s new Executive Chairman, succeeding Vaidheesh Annaswamy. The transition was revealed through a press release on the Bombay Stock Exchange (BSE). With this leadership change, Suven aims to accelerate its growth in the rapidly expanding contract development and manufacturing organization (CDMO) industry.

Sharma, who brings a wealth of experience from the biopharmaceutical sector, expressed enthusiasm for his new role at Suven. "This is an exciting time for the CDMO industry, particularly for Indian companies. Suven, with its strong track record and advanced technology capabilities, is well-positioned to capitalize on market opportunities. I am thrilled to join Suven and be part of a growth journey that will make a significant impact on transforming patient lives through innovation and collaboration," said Sharma in his statement.

Vaidheesh Annaswamy, who has led Suven to success during his tenure, has decided to transition from his board position and will now serve as Vice Chair of Suven's Advisory Council. Annaswamy commented, "At this stage of my career, I have chosen to take on an advisory role where I can continue to contribute to Suven's growth strategy. I am confident that Vivek’s leadership and industry expertise will carry forward the initiatives I set in motion, helping Suven become a leading tech-driven, diversified CDMO."

Sharma’s appointment marks an important moment for Suven, as the company continues to build on its established reputation for technological innovation and excellence in pharmaceutical manufacturing. With the combined insights of both Sharma and Annaswamy, Suven is set to embark on its next chapter of growth and transformation.